Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
[Psoriasis and cardiovascular disease]
Tiago Torres1, Rita Sales, Carlos Vasconcelos
1Serviço de Dermatologia. Centro Hospitalar do Porto. Porto. Portugal. Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal. tiagotorres2002@hotmail.com.
Insights
Psoriasis patients face higher risks of cardiovascular disease and metabolic issues due to chronic inflammation. Early screening for these conditions is crucial for better patient outcomes.
Area of Science:
- Dermatology
- Cardiology
- Endocrinology
Context:
- Psoriasis is a chronic, systemic inflammatory condition.
- It is frequently linked with cardiometabolic comorbidities.
- These include obesity, hypertension, diabetes, dyslipidaemia, and metabolic syndrome.
Purpose:
- To highlight the association between psoriasis and cardiovascular disease (CVD).
- To emphasize psoriasis as a potential independent risk factor for CVD and atherosclerosis.
- To alert clinicians about the necessity of screening and monitoring CVD risk factors in psoriasis patients.
Summary:
- Psoriasis is linked to significant cardiometabolic risks, including obesity, hypertension, diabetes, and metabolic syndrome.
- The chronic inflammation in psoriasis may independently contribute to cardiovascular disease and premature atherosclerosis.
- This review focuses on the spectrum of cardiometabolic comorbidities and elevated CVD risk in individuals with psoriasis.
Impact:
- Increased awareness among clinicians regarding the cardiovascular risks associated with psoriasis.
- Promotes proactive screening and management of cardiometabolic factors in psoriatic patients.
- Aims to reduce the incidence of cardiovascular events like myocardial infarction and stroke in this population.
Abstract:
Psoriasis is a common, chronic and systemic inflammatory disease associated with several comorbidities, such as obesity, hypertension, diabetes, dyslipidaemia and metabolic syndrome, but also with an increased risk of cardiovascular disease, like myocardial infarction or stroke. The chronic inflammatory nature of psoriasis has been suggested to be a contributing and potentially independent risk factor for the development of cardiovascular comorbidities and precocious atherosclerosis. Aiming at alerting clinicians to the need of screening and monitoring cardiovascular diseases and its risk factors in psoriatic patients, this review will focus on the range of cardiometabolic comorbidities and increased risk of cardiovascular disease associated with psoriasis.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Hypertension II: Pathophysiology
Rheumatic Heart Disease III: Medical Management

